Eagle Pharmaceuticals, Inc. Ownership
$0.97
0.00%
Nasdaq, Oct 08, 09:30 am EDT.
Eagle Pharmaceuticals, Inc. Top Shareholders
| # | Holder | Shares | % of Shares Out | Change | Filing Date |
|---|---|---|---|---|---|
| 1 |
Nantahala Capital Management, LLC
|
4.945m | — | — | Jun 30 2025 |
| 2 |
J. Goldman & Co., L.P.
|
667.108k | — | +667.108k | Jun 30 2025 |
| 3 |
Stanley-Laman Group, Ltd.
|
12.000k | — | — | Jun 30 2026 |
| 4 |
BlackRock Fund Advisors
|
2.310k | — | — | Jul 31 2026 |
| 5 |
Archer Investment Corporation
|
350.000 | — | — | Jun 30 2026 |
|
1
Nantahala Capital Management, LLC
|
4.945m
|
|
2
J. Goldman & Co., L.P.
|
667.108k
|
|
3
Stanley-Laman Group, Ltd.
|
12.000k
|
|
4
BlackRock Fund Advisors
|
2.310k
|
|
5
Archer Investment Corporation
|
350.000
|
| The largest shareholders show who really holds influence: big institutional owners shape a stock's liquidity, and building or cutting positions can move the price. |
Recent Eagle Pharmaceuticals, Inc. Insider Transactions
Powered by
| Date | Insider & Role | Type | Price | Quantity | Volume |
|---|---|---|---|---|---|
| Oct 10 2026 |
John Mitchell
CEO
|
Purchases
|
$182.45 | + 15,000 | $2,736,750 |
| Oct 07 2026 |
Sarah Chen
CFO
|
Sales
|
$179.80 | - 8,500 | $1,528,300 |
| Oct 03 2026 |
Robert Williams
COO
|
Purchases
|
$175.20 | + 12,000 | $2,102,400 |
| Sep 28 2026 |
Emily Rodriguez
Director
|
Sales
|
$181.30 | - 5,200 | $942,760 |
| Sep 22 2026 |
Michael Thompson
SVP Operations
|
Purchases
|
$170.50 | + 20,000 | $3,410,000 |
| Sep 15 2026 |
Lisa Park
General Counsel
|
Sales
|
$177.90 | - 6,800 | $1,209,720 |
| No transactions found for this filter. | |||||
|
John Mitchell
PURCHASES
|
Oct 10 2026
$182.45
|
|
Sarah Chen
SALES
|
Oct 07 2026
$179.80
|
|
Robert Williams
PURCHASES
|
Oct 03 2026
$175.20
|
|
Emily Rodriguez
SALES
|
Sep 28 2026
$181.30
|
|
Michael Thompson
PURCHASES
|
Sep 22 2026
$170.50
|
|
Lisa Park
SALES
|
Sep 15 2026
$177.90
|
| No transactions found for this filter. | |
| Insider transactions show you what executives, directors and major shareholders do with their own stock: people who know the company from the inside. Buys are the most telling signal, because insiders invest their own money. Sells are harder to read, since they can also be driven by taxes, diversification or expiring option programs. |
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
